D
Regeneron Pharmaceuticals, Inc. REGN
$589.48 -$8.68-1.45% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 3.17% 16.63% 11.61% 16.62% 0.53%
Total Depreciation and Amortization 12.56% 13.80% 14.70% 15.05% 14.65%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 35.26% -133.15% -54.29% -159.55% -89.83%
Change in Net Operating Assets 65.55% -980.76% -557.07% -269.85% -474.60%
Cash from Operations 16.53% -16.58% -3.78% -18.70% -14.10%
Capital Expenditure -19.95% -26.25% -5.19% -30.40% -26.61%
Sale of Property, Plant, and Equipment -100.00% -- -- -- --
Cash Acquisitions 80.80% 69.95% 69.95% 82.78% --
Divestitures -- -- -- -- --
Other Investing Activities 111.41% 118.28% 28.85% 51.50% 45.30%
Cash from Investing 76.12% 97.12% 22.51% 42.03% 34.54%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -74.09% -37.14% 27.92% 37.66% 33.33%
Repurchase of Common Stock -41.05% -46.34% -23.74% -12.26% 6.38%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -210.41% -134.90% -22.93% 5.06% 32.73%
Foreign Exchange rate Adjustments 237.50% 144.44% -75.00% 133.33% -100.00%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 506.51% 136.63% 34.80% 88.96% 98.53%